Suppr超能文献

1 型糖尿病患者胰腺移植后体重增加与血糖谱恶化相关:一项回顾性队列研究。

Weight gain following pancreas transplantation in type 1 diabetes is associated with a worse glycemic profile: A retrospective cohort study.

机构信息

Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Barcelona, Spain.

Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Barcelona, Spain.

出版信息

Diabetes Res Clin Pract. 2021 Sep;179:109026. doi: 10.1016/j.diabres.2021.109026. Epub 2021 Aug 26.

Abstract

AIMS

Evaluate the weight trajectories after pancreas transplantation (PT) and their relationships with pancreas graft outcomes in type 1 diabetes (T1D).

METHODS

Retrospective cohort study. T1D individuals who underwent PT were recruited (T1D-PT; n = 194) and divided into three groups according to transplantation date: 1999-2004 (n = 57), 2005-2009 (n = 79), 2010-2015 (n = 58). For weight comparisons, a random sample of T1D without renal impairment was also recruited during 2015 (n = 61; T1D-control).

RESULTS

The median follow-up for the T1D-PT group was 11.1 years. Despite significant weight loss at 6 months (65.7 ± 12.4 vs. 64.1 ± 11.4 Kg; p < 0.001), a stepped increase was seen thereafter (60 months: 68.0 ± 14.0 Kg; p < 0.001). Participants from the 2010-2015 period showed higher weight gain (p < 0.001), outweighing that observed in the T1D-control (60 months: +4.69 ± 8.49 vs. -0.97 ± 4.59 Kg; p = 0.003). Weight gain between 6 and 36 months was directly associated with fasting glucose and HbA1c at 36 months, and with HbA1c at 60 months (p < 0.05). However, in Cox-regression models adjusted for age, sex, and several recipient and PT-related variables, the third tertile of weight gain between 6 and 36 months showed a non-significant increase in the graft failure/dysfunction (HR 2.33 [0.75-7.27]).

CONCLUSIONS

Weight gain post-PT was associated with glucose-related biochemical markers of graft dysfunction, which needs confirmation in further studies.

摘要

目的

评估 1 型糖尿病(T1D)患者胰腺移植(PT)后的体重轨迹及其与胰腺移植物结局的关系。

方法

回顾性队列研究。招募接受 PT 的 T1D 个体(T1D-PT;n=194),并根据移植日期分为三组:1999-2004 年(n=57)、2005-2009 年(n=79)、2010-2015 年(n=58)。为了进行体重比较,在 2015 年还随机招募了一组无肾功能损害的 T1D 患者(n=61;T1D-对照组)。

结果

T1D-PT 组的中位随访时间为 11.1 年。尽管在 6 个月时体重显著减轻(65.7±12.4 与 64.1±11.4 Kg;p<0.001),但此后体重逐渐增加(60 个月:68.0±14.0 Kg;p<0.001)。2010-2015 年期间的参与者体重增加更多(p<0.001),超过了 T1D-对照组(60 个月:+4.69±8.49 与-0.97±4.59 Kg;p=0.003)。6-36 个月期间的体重增加与 36 个月时的空腹血糖和 HbA1c 以及 60 个月时的 HbA1c 直接相关(p<0.05)。然而,在调整年龄、性别以及多个受者和 PT 相关变量的 Cox 回归模型中,6-36 个月期间体重增加的第三 tertile 与移植物功能障碍/衰竭的风险增加无关(HR 2.33[0.75-7.27])。

结论

PT 后体重增加与与移植物功能障碍相关的葡萄糖相关生化标志物有关,这需要在进一步的研究中进行确认。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验